Policy | October 30, 2022
21.4 lakh TB cases notified in India in 2021
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Krsnaa Diagnostics now has its footprints in Delhi.
To address the preventive & primary healthcare delivery gaps in India
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Subscribe To Our Newsletter & Stay Updated
